Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in REPL — Replimune Group, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,805,691
-$1,967,748 QoQ
Shares Held
253,450
-59.4% QoQ
Ownership
0.269%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 199 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Derivatives in REPL

reported options exposure · as of Jun 30, 2026
CallValue
$12,216,852
CallShares
1,103,600
PutValue
$5,331,312
PutShares
481,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. REPL ranks #71 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in REPL

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,331,312 481,600
2026-06-30 $12,216,852 1,103,600
2026-06-30 $2,805,691 253,450
2026-03-31 $4,773,439 623,979
2026-03-31 $3,024,045 395,300
2026-03-31 $9,957,240 1,301,600
2025-12-31 $10,950,552 1,126,600
2025-12-31 $2,439,720 251,000
2025-12-31 $5,898,523 606,844
2025-09-30 $7,243,672 1,728,800
2025-09-30 $7,529,430 1,797,000
2025-06-30 $2,130,197 229,300
2025-06-30 $1,084,143 116,700
2025-06-30 $815,485 87,781
2025-03-31 $338,325 34,700
2025-03-31 $1,491,750 153,000
2025-03-31 $1,520,054 155,903
2024-12-31 $486,822 40,200
2024-12-31 $546,112 45,096
2024-12-31 $368,144 30,400
2024-09-30 $475,444 43,380
2024-06-30 $1,656,207 184,023
2024-06-30 $219,600 24,400
2024-06-30 $157,500 17,500
2024-03-31 $607,848 74,400
2024-03-31 $788,518 96,514
2024-03-31 $105,393 12,900
2023-12-31 $275,661 32,700
2023-12-31 $171,129 20,300
2023-12-31 $152,414 18,080
2023-09-30 $7,247,796 423,600
2023-09-30 $1,226,940 71,709
2023-09-30 $5,444,402 318,200
2023-06-30 $3,731,454 160,700
2023-06-30 $503,874 21,700
2023-06-30 $3,065,690 132,028
2023-03-31 $1,519,077 86,018
2022-12-31 $1,150,560 42,300
2022-12-31 $558,769 20,543
2022-09-30 $721,886 41,800
2022-09-30 $727,118 42,103
2022-06-30 $424,764 24,300
2022-03-31 $833,242 49,072
2021-12-31 $1,679,495 61,974
2021-09-30 $1,223,153 41,267
2021-06-30 $2,365,288 61,564
2021-06-30 $749,190 19,500
2021-03-31 $1,040,391 34,100
2021-03-31 $1,496,301 49,043
2020-12-31 $1,022,420 26,800